All Phenotypes Trp53bp2<+> MGI Mouse

About Help FAQ

Phenotypes associated with this allele

Allele Symbol
Allele Name
Allele ID

Trp53bp2⁺
wild type
MGI:3049973

Summary

8 genotypes

Jump to	Allelic Composition	Genetic Background	Genotype ID
ht1	Trp53bp2^tm1Xlu/Trp53bp2⁺	B6.129S6-Trp53bp2^tm1Xlu	MGI:6191759
ht2	Trp53bp2^tm1Xlu/Trp53bp2⁺	C.129S6-Trp53bp2^tm1Xlu	MGI:6191760
ht3	Trp53bp2^{tm1b(EUCOMM)Hmgu}/Trp53bp2⁺	C57BL/6N-Trp53bp2^{tm1b(EUCOMM)Hmgu}/H	MGI:6679323
ht4	Trp53bp2^tm1Cdlo/Trp53bp2⁺	involves: 129S1/Sv * 129X1/SvJ * C57BL/6	MGI:3839866
ht5	Trp53bp2^tm1Xlu/Trp53bp2⁺	involves: 129S6/SvEvTac * C57BL/6J	MGI:3629204
cx6	Trp53^tm1Brd/Trp53⁺ Trp53bp2^tm1Cdlo/Trp53bp2⁺	involves: 129S1/Sv * 129S7/SvEvBrd * 129X1/SvJ * C57BL/6	MGI:3839867
cx7	Trp53bp2^tm1Cdlo/Trp53bp2⁺ Tg(EmuSR-tTa)83Bop/0 Tg(tetO-MYC)36aBop/0	involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * FVB/N	MGI:3839868
cx8	Trp53^tm1Tyj/Trp53⁺ Trp53bp2^tm1Xlu/Trp53bp2⁺	involves: 129S2/SvPas * 129S6/SvEvTac * C57BL/6J	MGI:3629207

Allelic Composition	Trp53bp2^tm1Xlu/Trp53bp2⁺
Genetic Background	B6.129S6-Trp53bp2^tm1Xlu

Find Mice

Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Trp53bp2^tm1Xlu mutation (0 available); any Trp53bp2 mutation (52 available)

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

cardiovascular system

ventricular septal defect ( J:240594 )

• 30% incidence of ventricular septal defect

craniofacial

cleft palate ( J:240594 )

• 30% incidence of cleft palate

digestive/alimentary system

cleft palate ( J:240594 )

• 30% incidence of cleft palate

growth/size/body

cleft palate ( J:240594 )

• 30% incidence of cleft palate

nervous system

abnormal spinal cord central canal morphology ( J:240594 )

• 20% incidence of spinal canal abnormalities

vision/eye

abnormal retina morphology ( J:240594 )

• 30% incidence of retinal abnormalities

Allelic Composition	Trp53bp2^tm1Xlu/Trp53bp2⁺
Genetic Background	C.129S6-Trp53bp2^tm1Xlu

Find Mice

Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Trp53bp2^tm1Xlu mutation (0 available); any Trp53bp2 mutation (52 available)

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

cardiovascular system

ventricular septal defect ( J:240594 )

• 13% incidence of ventricular septal defect

hemorrhage ( J:240594 )

• small patches of subcranial hemorrhage

embryo

abnormal embryonic neuroepithelium morphology ( J:240594 )

• 25% of embryos show localized abnormalities in the distribution of neuroepithelial brain tissue associated with small patches of subcranial hemorrhage

nervous system

abnormal embryonic neuroepithelium morphology ( J:240594 )

• 25% of embryos show localized abnormalities in the distribution of neuroepithelial brain tissue associated with small patches of subcranial hemorrhage

abnormal lateral ventricle morphology ( J:240594 )

• 25% incidence of asymmetric lateral ventricles

Allelic Composition	Trp53bp2^{tm1b(EUCOMM)Hmgu}/Trp53bp2⁺
Genetic Background	C57BL/6N-Trp53bp2^{tm1b(EUCOMM)Hmgu}/H
Cell Lines	HEPD0778_8_A12

Find Mice

Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Trp53bp2^{tm1b(EUCOMM)Hmgu} mutation (1 available); any Trp53bp2 mutation (52 available)

Data Sources

IMPC Data for Trp53bp2

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

behavior/neurological

hyperactivity ( J:211773 )

IMPC - HAR

hematopoietic system

increased hemoglobin content ( J:211773 )

IMPC - HAR

homeostasis/metabolism

increased circulating aspartate transaminase level ( J:211773 )

IMPC - HAR

Allelic Composition	Trp53bp2^tm1Cdlo/Trp53bp2⁺
Genetic Background	involves: 129S1/Sv * 129X1/SvJ * C57BL/6

Find Mice

Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Trp53bp2^tm1Cdlo mutation (0 available); any Trp53bp2 mutation (52 available)

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

neoplasm

increased tumor incidence ( J:146764 )

• increased tumor incidence but the spectrum of tumor types is similar to controls

increased incidence of tumors by ionizing radiation induction ( J:146764 )

• unlike wild-type controls, mice develop tumors following exposure to 6.0 Gy or 10.5 Gy of gamma-radiation

• induced tumors are high grade lymphomas

immune system

abnormal T cell physiology ( J:146764 )

• attenuated T cell apoptotic response following gamma-irradiation

cellular

abnormal cell cycle checkpoint function ( J:146764 )

• attenuated G0/G1 checkpoint function following gamma-irradiation

hematopoietic system

abnormal T cell physiology ( J:146764 )

• attenuated T cell apoptotic response following gamma-irradiation

homeostasis/metabolism

increased incidence of tumors by ionizing radiation induction ( J:146764 )

• unlike wild-type controls, mice develop tumors following exposure to 6.0 Gy or 10.5 Gy of gamma-radiation

• induced tumors are high grade lymphomas

Allelic Composition	Trp53bp2^tm1Xlu/Trp53bp2⁺
Genetic Background	involves: 129S6/SvEvTac * C57BL/6J

Find Mice

Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Trp53bp2^tm1Xlu mutation (0 available); any Trp53bp2 mutation (52 available)

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

neoplasm

increased tumor incidence ( J:108701 )

• incidence of tumors (12/20) is much higher in heterozygous mice than in wild-type mice (4/18) over a 3 year period

increased incidence of tumors by ionizing radiation induction ( J:108701 )

• more irradiated heterozygotes (9/19) develop tumors than untreated heterozygotes (1/19) or irradiated wild-type mice (3/19)

increased rhabdomyosarcoma incidence ( J:108701 )

• 1/20 spontaneously developed this sarcoma: only observed in irradiated heterozygous mice, not in wild-type

increased lymphoma incidence ( J:108701 )

• 40% of mice develop lymphomas; in wild-type this is the only type of tumor occurring tumor origin is determined to be T and B cell-derived

increased T cell derived lymphoma incidence ( J:108701 )

• T cell lymphomas in various tissues are observed in both irradiated heterozygous and wild-type mice

increased squamous cell carcinoma incidence ( J:108701 )

• 1/20 showed squamous cell carcinoma

increased hemangiosarcoma incidence ( J:108701 )

• 2/20 heterozygotes developed angiosarcoma

muscle

increased rhabdomyosarcoma incidence ( J:108701 )

• 1/20 spontaneously developed this sarcoma: only observed in irradiated heterozygous mice, not in wild-type

endocrine/exocrine glands

increased T cell derived lymphoma incidence ( J:108701 )

• T cell lymphomas in various tissues are observed in both irradiated heterozygous and wild-type mice

hematopoietic system

increased T cell derived lymphoma incidence ( J:108701 )

• T cell lymphomas in various tissues are observed in both irradiated heterozygous and wild-type mice

immune system

increased T cell derived lymphoma incidence ( J:108701 )

• T cell lymphomas in various tissues are observed in both irradiated heterozygous and wild-type mice

homeostasis/metabolism

increased incidence of tumors by ionizing radiation induction ( J:108701 )

• more irradiated heterozygotes (9/19) develop tumors than untreated heterozygotes (1/19) or irradiated wild-type mice (3/19)

Allelic Composition	Trp53^tm1Brd/Trp53⁺ Trp53bp2^tm1Cdlo/Trp53bp2⁺
Genetic Background	involves: 129S1/Sv * 129S7/SvEvBrd * 129X1/SvJ * C57BL/6

Find Mice

Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Trp53bp2^tm1Cdlo mutation (0 available); any Trp53bp2 mutation (52 available)
Trp53^tm1Brd mutation (5 available); any Trp53 mutation (237 available)

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

neoplasm

increased tumor incidence ( J:146764 )

• increased tumor incidence compared to wild-type controls but not compared to mice heterozygous for the Trp53 allele alone

Allelic Composition	Trp53bp2^tm1Cdlo/Trp53bp2⁺ Tg(EmuSR-tTa)83Bop/0 Tg(tetO-MYC)36aBop/0
Genetic Background	involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * FVB/N

Find Mice

Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Tg(EmuSR-tTa)83Bop mutation (1 available)
Tg(tetO-MYC)36aBop mutation (1 available)
Trp53bp2^tm1Cdlo mutation (0 available); any Trp53bp2 mutation (52 available)

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

neoplasm

increased T cell derived lymphoma incidence ( J:146764 )

• incidence of T cell lymphomas is similar to that in transgenic mice wild-type for Trp53bp2

endocrine/exocrine glands

increased T cell derived lymphoma incidence ( J:146764 )

• incidence of T cell lymphomas is similar to that in transgenic mice wild-type for Trp53bp2

hematopoietic system

increased T cell derived lymphoma incidence ( J:146764 )

• incidence of T cell lymphomas is similar to that in transgenic mice wild-type for Trp53bp2

immune system

increased T cell derived lymphoma incidence ( J:146764 )

• incidence of T cell lymphomas is similar to that in transgenic mice wild-type for Trp53bp2

Allelic Composition	Trp53^tm1Tyj/Trp53⁺ Trp53bp2^tm1Xlu/Trp53bp2⁺
Genetic Background	involves: 129S2/SvPas * 129S6/SvEvTac * C57BL/6J

Find Mice

Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Trp53bp2^tm1Xlu mutation (0 available); any Trp53bp2 mutation (52 available)
Trp53^tm1Tyj mutation (12 available); any Trp53 mutation (237 available)

♀	phenotype observed in females
♂	phenotype observed in males
N	normal phenotype

neoplasm

increased tumor incidence ( J:108701 )

• 26% of double heterozygotes develop tumors over a 72 week period

increased lymphoma incidence ( J:108701 )

• lymphoma development is accelerated in compared to Trp53 heterozygotes with wild-type Trp53bp2; at 42 weeks there is a significant difference in the onset between the two genotypes

• at 72 weeks the difference in onset of lymphoma development is not significant

Contributing Projects: Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources Funding Information Warranty Disclaimer, Privacy Notice, Licensing, & Copyright Send questions and comments to User Support.	last database update 12/30/2025 MGI 6.24